Sitemap
- ______ $3,015,000 - Drug Manufacturer Settles with Patients Injured by Cholesterol Drug
- ______ $375,000 - Drug Manufacturer Settles Product Liability/Wrongful Death Claim
- ______ $4,555,000 for 13 class action plaintiffs. - Cholesterol Drug Manufacturer Pays $4.55 Million to Baycol Victims
- ______ $2,100,000 - Woman's Estate Settles with Internist Following Liver Failure
- ______ RECOVERY Products liability/Medical malpractice - Lack of informed consent - Plaintiff's decedent dies two months after taking Baycol, a cholesterol-reducing drug, in combination with Lopid - Adverse reaction to the medication - Rhabdomyolysis.
- ______ RECOVERY - PRODUCT LIABILITY - FAILURE TO WARN - RHABDOMYOLYSIS RELATED TO USE OF BAYCOL - ACUTE RENAL FAILURE - WRONGFUL DEATH OF 87-YEAR-OLD FEMALE.
- ______ VERDICT Product liability - Alleged dangerous pharmaceutical drug - p 7 3 Claimed failure to warn regarding Baycol use - Severe myalgia - Muscle pain and cramping.
- ______ VERDICT Alleged dangerous pharmaceutical drug -Claimed failure to warn regarding Baycol use - Severe myalgia - Muscle pain and cramping.
- Keller Rohrback Announces Arizona Class Action Litigation Related to ...
- Patients Become Plaintiffs Will Provide Readers with All They Need to ...
- 'Judicial hellhole' is junk journalism
- Cholesterol Treatment
- Morning business file: EnCana deal
- Cellino & Barnes Announces $4.85 Billion Vioxx Settlement
- FDA still too chummy with pharmaceutical industry, critics say
- Cell News Opens Door To Drug Discovery
- Cell News Opens Door To Drug Discovery
- Merck/Schering-Plough Pharmaceuticals Provides Update on ENHANCE
- hwp16.11.;Taking fight out of Merck
- Morning business file: Security revenues up
- Heart Bypass Surgery Drug Causing Kidney/Renal Failure Suspended ...
- Bayer suspends anti-bleeding drug
- Bayer suspends sale of blood drug on world markets
- FDA Moves To Shut Down Red Yeast Rice Distributors Online
- Prescriptions for Growth
- A Win for Patients
- Is FDA Capable Of Keeping Food Safe?
- Lesbian Health
- Drugs for 'Good' Cholesterol Fail Test
- Experimental drugs to raise 'good' cholesterol fail
- Trial Cholesterol Drug Strikes Out
- Personnel: St. Mary's announces employee of the month
- Deaths Spur Cholesterol Drug Recall
- From the analyst's couch : Clinical forecasting in drug development
- Today's news and more
- A sick agency in need of a cure?
- Business notes
- State gets $200,000 in Bayer settlement
- Mississippi Top News This Hour
- Business Digest
- Bayer settles Baycol charges with 30 states
- Florida: Bayer Settles An $8 Million Multi-State Agreement Over Its ...
- Olympia to get a check from Bayer
- SC Among 30 States in $8 million Settlement with Bayer Corp.
- States, Bayer Reach Settlement in Drug Lawsuit
- Desert Whispers
- Protested drug firm finds new site
- Protested drug firm finds new site
- Med School bans pharmaceutical freebies
- Panel Says US Drug Safety System Needs Major Reforms
- We need a ‘learner’s permit’ for new drugs
- Other voices: A license for safer drugs
- A License for Safer Drugs
- Gary Crandall, CEO
- American farmers sue Bayer over GM rice
- American farmers sue Bayer over GM rice
- Bayer says 3,000 Lipobay/Baycol cases pending on Aug 18
- The sales growth, on a continuing-operations basis, was led by its ...
- Crestor side effects higher than thought
- Marchin' for Merck in New Orleans
- Public Citizen: Hormone Replacement Therapy Drugs Mixed by Pharmacies ...
- the zeitgeist checklist
- FDA to frame guidelines on outside experts with industry ties
- Lipid-lowering drugs
- Law Offices of Peter G. Angelos Investigate Claims for Bausch & Lamb ...
- FDA's Monitoring of Post-approval Studies Inadequate - Report
- Lawyers gear up to attack Fosamax
- Lawyers mobilize quickly on drug cases
- Bayer starts €1.2 bln share sale for Schering
- Featured Tools Sponsored by
- Despite the claims of the mainstream media, Lesco and other statins ...
- Rosuvastatin: An Independent Analysis of Risks and Benefits
- People's Pharmacy: FDA lacking in oversight of approved drugs
- Class Actions Are Here to Stay
- N.Y. Comptroller Seeks to Jettison Milberg as Pension Fund Counsel
- Spelling Bee draws interest from online gamblers
- BBC to offer Americans an alternative for morning TV
- Greater use of cholesterol drug urged to fight heart disease
- Spitzer Returning Funds to Firm
- Lieff Cabraser
- Heimann & Bernstein
- 8th Circ. Upholds Another Dismissal In Baycol MDL
- Hinds judge says he won't seek re-election
- Rhabdomyolysis Lawsuits
- Attacking high cholesterol
- FDA approves Symbyax for treatment-resistant depression
- Pharma Bucks Recession with "Treatment Resistant" Conditions
- Bayer taps Dekkers as new CEO in overhaul
- Attorney General Martha Coakley Enters Agreement With Bayer ...
- Lower the "Bad" Cholesterol for
- Statin Warning For Pregnant Women
- Symptoms of Heart Attack in Women
- Bayer must alter birth-control ads
- Drug-Induced Dementia and Delirium Common in Seniors But Often ...
- How To Maintain FDA Standards
- Editorial: Don’t be a guinea pig
- Statins May Cause Muscle Damage in Some Patients
- Oregon settles with drug maker
- Taking Statins To The Next Level
- Astra drug Crestor finally gets German green light
- Pfizer CEO Kindler Calls for More Science, Less Politics at FDA
- An Analysis of Effective Drug Life Cycle Management: Understand the ...
- Small Swedish Pharma Could Be Buyout Target for Pfizer
- Drugs Approved Under Deadline More Likely to Run Into Trouble Later
- Today in History - March 18
- Drugs Approved Under Deadline More Likely to Run Into Trouble Later
- FDA Deadlines May Impact Drug Safety
- Special Masters Appointed in Program to Resolve U.S. VIOXX(R) Product ...
- More Baycol MSN Newsfeeds...
- Nhóm thu?c statin di?u tr? r?i lo?n m? máu - XãLu?n.com tin t?c Vi?t Nam c?p nh?t 24 gi?
- Laws, Life, and Legal Matters - Court Cases and Legal Information at Leagle.com - All Federal and State Appeals Court Cases in One Search
- Laws, Life, and Legal Matters - Court Cases and Legal Information at Leagle.com - All Federal and State Appeals Court Cases in One Search
- Public Citizen Sues FDA for Failure to Act on Darvon
- Live 5 News, Weather Sports, Traffic, and Programming Guide for Charleston, SC | Consumer group sues FDA, arguing it failed to act on risky painkiller
- FDA sued over failure to ban painkiller - FierceHealthcare
- Group Wants FDA to Ban Painkiller
- The Associated Press: FDA sued for failure to act on risky painkiller
- Around the Nation - washingtonpost.com
- Judicial opinions with weight, wit
- MPR: U. S. Dist. Judge Davis makes history as new chief of Minn.'s federal bench
- Drug Makers Say FDA Safety Focus Is Slowing New-Medicine Pipeline - WSJ.com
- Do Quick Approvals Mean Risky Drugs? - Health - redOrbit
- Citizens uniting against fluoride
- Common Ground - May 08
- November 2001 archives, part 1
- October 2000 archives, part 2
- October 2001 archives, part 1
- October 2001 archives, part 3
- Look at evidence for new drugs- Syracuse.com
- Apply safety standards to emerging biologics -- Page 1 -- Times Union - Albany NY
- DOTmed.com - OEC OK'ed by FDA to Re-start Production
- Stryker gets FDA Warning for Quality Issues, False Documentation - International Business Times -
- Statins and their side effects by Harvard Health Publications harvard health, harvard medical school, statins | Gather
- ottawasun.com - National/World - Surgery drug determined too deadly
- Study Prompts Bayer to Pull Trasylol from the Market
- Medical News: Aprotinin (Trasylol) Down But Not Totally Out - in Product Alert, Prescriptions from MedPage Today
- Trasylol Gone for Good
- Could This Be the Final Nail in the Coffin for Trasylol?
- Bayer withdraws Trasylol from U.S. market - UPI.com
- Is this the end of the Trasylol story? - FiercePharma
- Prescribing Reference: Drug News - Trasylol withdrawn from market
- Trasylol Drug Stays Off Market - EON
- Canadian Study Links Bayer Drug To Increased Risk Of Death | DogFlu.ca
- Bayer to remove Trasylol from the market, FDA - The Money Times
- Study hammers last nail in the coffin for Bayer's Trasylol - Medical Marketing and Media
- Final Blow To Trasylol, Bayer Pulls Remaining Stocks - TheMedGuru
- InteliHealth:
- Bayer: A History of Profit from Suffering
- Bayer's Trasylol raises death rate, study finds | Industries | Healthcare | Reuters
- Study finds patients given popular heart drug aprotinin had higher risk of dying
- Bayer anti-bleeding drug associated with higher death rate
- Danger From Heart Surgery Drug Confirmed - washingtonpost.com
- AFP: Drug aprotinin boosts risk of death: study
- US FDA: Bayer to remove rest of Trasylol supplies | Deals | Regulatory News | Reuters
- Bayer Healthcare to remove remaining Trasylol from market: FDA - Forbes.com
- Bayer pulls Trasylol supplies after study | Deals | Regulatory News | Reuters
- Bloomberg.com: Germany
- Bayer Antibleeding Drug Takes Hit - WSJ.com
- The Associated Press: Study likely spells end for anti-bleeding drug
- Class Action Newsline
- Patients Become Plaintiffs Will Provide Readers with All They Need to Know about Product Liability Regulation to Protect Their Business
- Pharmaceutical Industry Seeks to Improve Rx Development in an Extremely Tough Climate
- The Times-Tribune - Grapefruit bad medicine with some drugs
- NEJM -- Sign In
- JTCS -- Sign In Page
- Medical News: AHA: Torcetrapib Toxicity May Be Molecule Not Class-Related - in Meeting Coverage, AHA from MedPage Today
- FDA – Drug Industry Relationship Too Close for Comfort
- AFP: German pharmaceutical group Bayer suspends sale of blood-clotting drug
- RT? Business: Bayer Q3 net profit surges nearly fourfold
- Big Drugmakers Need To Improve Their Act Already - Seeking Alpha
- Lubuskie - informacje, artykuy, wydarzenia - gazetalubuska online
- Lubuskie - informacje, artykuy, wydarzenia - gazetalubuska online
- autoweb.cz
- autoweb.cz
- Lyceens.org
- Bloomberg.com: Germany
- Bayer aims to directly sell cholesterol pill - International Herald Tribune
- autoweb.cz
- The Wall Street Journal
- Bayer faces healthier future - Financial Times - MSNBC.com
- Lyceens.org
- autoweb.cz
- Statins Are Safe and Do What Their Makers Claim - CME Teaching Brief® - MedPage Today
- Wait Before Using Type 2 Diabetes Drug Januvia, Public Citizen Advises on WorstPills.org | All American Patriots
- JAPMA -- Sign In Page
- America can't afford much more drug industry charity - Roanoke.com
- Is FDA Capable Of Keeping Food Safe?, Experts Say Understaffed Agency Is Unable To Prevent Future Outbreaks Of Contaminated Food - CBS News
- WebWire | Vioxx Litigation Update
- 'Good' cholesterol drugs fail key tests - Health Care - MSNBC.com
- 9NEWS - Article - Animal antibiotic caution
- U.S. Food Supply at High Risk of Terrorist or Profit-Driven Tampering
- cbs4.com - Report: FDA Knew Of Food Issues Before Recall
- Aware of dangers | ScrippsNews
- FDA knew of contamination tied to outbreaks
- Chew cud, not antibiotics - The Boston Globe
- Putting the F Back in F.D.A. - The Lede - Breaking News - New York Times Blog
- Wired Science - Wired News
- Report: FDA knew peanut butter plant had problems - On Deadline - USATODAY.com
- India's Wockhardt gets US FDA nod for lisinopril | Breaking City News | Reuters.co.uk
- Wockhardt gets U.S. FDA nod for lisinopril | Reuters.com
- FDA says probing "thousands" of hogs for tainted feed | Bonds News | Reuters.com
- Missouri poultry farm may have tainted food-FDA| News| Bonds News| Reuters
- Democrats want more federal control on food safety - washingtonpost.com
- WebWire | Worldwide Fish & Seafood, Inc. Enters Consent Decree with FDA
- FDA knew about food problems, reports say | TheNewsTribune.com | Tacoma, WA
- More Baycol News Articles...
- Baycol: A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
- Rhabdomyolysis - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
- Local man sues over anti-cholesterol drug.(Health)(Recall: Pleasant Hill man blames Baycol for severe muscle disease.) : An article from: The Register-Guard (Eugene, OR)
- Postmarketing Surveillance. (Heart Of The Matter). : An article from: Internal Medicine News
- Baycol - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
- Patients voice concerns about statin side effects. (Main Deterrent to Compliance).(Brief Article) : An article from: Family Practice News
- El Baycol y la crisis de Bayer.(Bayer AG retira medicina del mercado)(TT: Baycol and Bayer's management crisis.)(TA: Bayer AG withdraws drug from market)(Artículo Breve) : An article from: Siempre!
- Rhabdomyolysis: the hidden killer. (Clinical Practice). : An article from: MedSurg Nursing
- Fatal rhabdomyolysis caused by lipid-lowering therapy.(Statistical Data Included) : An article from: Southern Medical Journal
- Rhabdomyolysis: A Case Study. : An article from: MedSurg Nursing
- Rhabdomyolysis associated with quinacrine therapy in a patient with chronic cutaneous lupus erythematosus.(CASE REPORTS) : An article from: Journal of Drugs in Dermatology
- Acute Renal Failure Related to Rhabdomyolysis: Pathophysiology, Diagnosis, and Collaborative Management.(Statistical Data Included) : An article from: Nephrology Nursing Journal
- Selective serotonin reuptake inhibitor-induced rhabdomyolysis associated with irinotecan.(Case Report) : An article from: Southern Medical Journal
- Rhabdomyolysis associated with simvastatin-nefazodone therapy.(Case Report) : An article from: Southern Medical Journal
- Antihistamine-induced rhabdomyolysis.(Case Report) : An article from: Southern Medical Journal
- Rhabdomyolysis from simvastatin triggered by infection and muscle exertion.(Case Reports) : An article from: Southern Medical Journal
- Rosuvastatin linked to excess adverse events: use is associated with reports of rhabdomyolysis, proteinuria, nephropathy, and renal failure.(Cardiovascular ... : An article from: Family Practice News
- Rhabdomyolysis of infectious and noninfectious causes. (Review Articles). : An article from: Southern Medical Journal
- Rhabdomyoma of the larynx: case report and clinical and pathologic review. : An article from: Ear, Nose and Throat Journal
- Massive honey bee envenomation-induced rhabdomyolysis in an adolescent. : An article from: Pediatrics
- Primary human immunodeficiency virus type 1 infection in a patient with acute rhabdomyolysis.(Case Report) : An article from: Southern Medical Journal
- Metabolic Complications of Acute Arterial Occlusions and Related Conditions/Myonephropathic-Metabolic Syndrome
- Pathogenesis and treatment of rhabdomyolysis : An article from: Journal of the American Academy of Nurse Practitioners
- Delayed rhabdomyolysis after ecstasy use : An article from: Mayo Clinic Proceedings
- Rhabdomyolysis - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
- With statin, fenofibrate safer than gemfibrozil: risk for rhabdomyolysis increased significantly when gemfibrozil was combined with most statins.(Cardiovascular ... : An article from: Internal Medicine News
- Returning vets offer a window on neuroscience: military centers are leading the way on cerebral vasospasm, ALS, and rhabdomyolysis research.(Clinical Rounds)(Comprehensive ... : An article from: Family Practice News
- Watch rhabdomyolysis in substance abusers. (Inexpensive Test Available).(Brief Article) : An article from: Clinical Psychiatry News
- Acute rhabdomyolysis from eating quail (ONR London report ; R-8-77) (ONR London report ; R-8-77)
- Rhabdomyolysis due to pulsed electric fields
- German and American Crisis Coverage- Treatment of the Baycol/Lipbay Crisis in Elite Newspapers
- Attorneys press discovery effort in litigation over cholesterol drug.: An article from: Trial
- News Potpourri (*). (Special Feature).: An article from: Southern Medical Journal
- El Baycol y la crisis de Bayer.(Bayer AG retira medicina del mercado)(TT: Baycol and Bayer's management crisis.)(TA: Bayer AG withdraws drug from market)(Artículo Breve): An article from: Siempre!
- Local man sues over anti-cholesterol drug.(Health)(Recall: Pleasant Hill man blames Baycol for severe muscle disease.): An article from: The Register-Guard (Eugene, OR)
- Patients voice concerns about statin side effects. (Main Deterrent to Compliance).(Brief Article): An article from: Family Practice News
- Postmarketing Surveillance. (Heart Of The Matter).: An article from: Internal Medicine News
- The impact of the Baycol withdrawal
- Randomized comparison of the efficacy and safety of cerivastatin and pravastatin in 1030 hypercholesterolenic patients: An article from: Mayo Clinic Proceedings




